Atlas Trials

Impact of Rifabutin on the Pharmacokinetics of Elexacaftor/Tezacaftor/Ivacaftor

Clinical trial NCT04840862 · COMPLETED

Trial details

NCT number
NCT04840862
Sponsor
University of Southern California
Status
COMPLETED
Phase
Phase 4
Study type
INTERVENTIONAL
Drug Drug Interaction
Start date
2022-05-09
Primary completion
2024-05-30
Enrollment
6

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.